Xvivo Perfusion Balance Sheet Health
Financial Health criteria checks 6/6
Xvivo Perfusion has a total shareholder equity of SEK2.0B and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK2.3B and SEK250.5M respectively. Xvivo Perfusion's EBIT is SEK13.2M making its interest coverage ratio -5.7. It has cash and short-term investments of SEK511.2M.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | -5.7x |
Cash | kr511.15m |
Equity | kr2.00b |
Total liabilities | kr250.54m |
Total assets | kr2.25b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: XVIP.F's short term assets (SEK830.7M) exceed its short term liabilities (SEK199.8M).
Long Term Liabilities: XVIP.F's short term assets (SEK830.7M) exceed its long term liabilities (SEK50.7M).
Debt to Equity History and Analysis
Debt Level: XVIP.F is debt free.
Reducing Debt: XVIP.F has no debt compared to 5 years ago when its debt to equity ratio was 1.5%.
Debt Coverage: XVIP.F has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: XVIP.F has no debt, therefore coverage of interest payments is not a concern.